|
|
Metal Nanoparticles in PharmaEdited by Ranjita Shegokar
Completely dedicated to the biomedical applications of metal
nanoparticles, this book covers the different toxicity problems found in
healthcare situations and also provides comprehensive info on the use of metal
nanoparticles in treating various diseases. Metal Nanoparticles in Pharma is
the first edited volume to set up the discussion for a clinical setting and to
target a pharmaceutical audience of academic and industry-based researchers
Metal Nanoparticles in Pharma, Mahendra Rai and Ranjita Shegokar (Editors)
Springer publishing house, proposed publication, ISBN 978-3-319-63789-1
(Hard cover) / ebook |
Emerging Nanotechnologies in ImmunologyEdited by Ranjita Shegokar
Emerging Nanotechnologies in Immunology aims to deliver a systematic and comprehensive review of data concerning the nature of interaction and nano-related risks between the nanophamaceuticals currently in the pipeline of S&T development for skin, ocular, and nasal drug delivery, including absorption, toxicity, and the ability to distribute after systemic exposure. The scientific development of manufactured nanomaterials for drug delivery is increasing rapidly. One of the most prominent applications is topical drug delivery, where cutaneous, ocular, and nasal exposure becomes even more relevant. These targets are the first barrier that nanoparticles encounter when in contact with the human body. The contributors addresses a representative set of the broad spectrum of nanopharmaceuticals currently being used, including cationic lipid nanoparticles, polymeric PLGA, PLA nanoparticles, biomacromolecules-based nanoparticles, and other scaffolds tissue engineered skin substitutes. Regulation and risk is also covered, since the safety of these nanophamaceuticals still represents a barrier to their wide innovative use. View less > “Emerging Nanotechnologies in Immunology: The Design, Application and
Toxicology of Nanopharmaceuticals and Nanovaccines” Edited by Shegokar
R., and Souto E.B. Elsevier Int publishing house, |
|
|
volume
1 |
NanopharmaceuticalsEdited by Ranjita Shegokar
Nanopharmaceuticals reviews advances in the drug delivery field via nanovehicles or nanocarriers that offer benefits like targeted therapy and serves as a single dose magic bullet for multiple drug delivery with improved drug efficiency at a lower dose, transportation of the drug across physiological barriers as well as reduced drug-related toxicity. The chapters are written by a diverse group of international researchers from industry and academia. The series Expectations and Realities of Multifunctional Drug Delivery Systems examines the fabrication, optimization, biological aspects, regulatory and clinical success of wide range of drug delivery carriers. This series reviews multifunctionality and applications of drug delivery systems, industrial trends, regulatory challenges and in vivo success stories. Throughout the volumes discussions on diverse aspects of drug delivery carriers, such as clinical, engineering, and regulatory, facilitate insight sharing across expertise area and form a link for collaborations between industry-academic scientists and clinical researchers. Multifunctional Drug Delivery systems: Expectations and Realities, Ranjita
Shegokar (editor) Volume 1 – Nanopharmaceuticals, Elsevier Int (Q1/2020) |
Delivery of DrugsEdited by Ranjita Shegokar
Delivery of Drugs: Expectations and Realities of Multifunctional Drug Delivery Systems, Volume Two examines the formulation of micro-nanosized drug delivery systems and recaps opportunities for using physical methods to improve efficacy via mechano-, electroporation. The book highlights innovative delivery methods like PIPAC, including discussions on the regulatory aspects of complex injectables. Written by a diverse range of international researchers from industry and academia, the chapters examine specific aspects of characterization and manufacturing for pharmaceutical applications as well as regulatory and policy aspects. This book connects formulation scientists, regulatory experts, engineers,
clinical experts and regulatory stakeholders. This level of discussion makes
it a valuable reference resource for researchers in both academia and the
pharmaceutical industry who want to learn more about the status of drug
delivery systems. Multifunctional Drug Delivery:Expectations and Realities, Ranjita Shegokar
(editor), Volume 2 – Delivery of Drugs, Elsevier Int (Q1/2020) |
volume
2 |
|
volume
3 |
Drug Delivery TrendsEdited by Ranjita Shegokar
Drug Delivery Trends examines a drift in the pharmaceutical field across the wide range of dosage forms, drug delivery systems (micro and nanoparticulate), at the regulatory front and on new types of therapies in the market. This volume additionally covers the challenges on drug delivery systems in terms of preclinical and current ways of determining quality and the options to solve the challenges associated with this. Most small-medium scale industries and academics struggle with initial regulatory challenges so a detailed discussion on regulatory trend covers the necessary basic understanding of regulatory procedures and provides the required guidance. The series Expectations and Realities of Multifunctional Drug Delivery Systems examines the fabrication, optimization, biological aspects, regulatory and clinical success of wide range of drug delivery carriers. This series reviews multifunctionality and applications of drug delivery systems, industrial trends, regulatory challenges and in vivo success stories. Throughout the volumes discussions on diverse aspects of drug delivery carriers, such as clinical, engineering, and regulatory, facilitate insight sharing across expertise area and form a link for collaborations between industry-academic scientists and clinical researchers. Multifunctional Drug Delivery: Expectations and Realities, Ranjita Shegokar
(editor), Volume 3 – Drug Delivery Trends, Elsevier Int (Q1/2020) |
Drug Delivery AspectsEdited by Ranjita Shegokar
Drug Delivery Aspects reviews additional features of drug delivery systems, along with the standard formulation development, like preclinical testing, conversion into solid dosage forms, roles of excipients and polymers used on stability and sterile processing. There is a focus on formulation engineering and related large scale (GMP) manufacturing, regulatory, and functional aspects of drug delivery systems. A detailed discussion on biologics and vaccines gives insights to readers on new developments in this direction. The series Expectations and Realities of Multifunctional Drug Delivery Systems examines the fabrication, optimization, biological aspects, regulatory and clinical success of wide range of drug delivery carriers. This series reviews multifunctionality and applications of drug delivery systems, industrial trends, regulatory challenges and in vivo success stories. Throughout the volumes discussions on diverse aspects of drug delivery carriers, such as clinical, engineering, and regulatory, facilitate insight sharing across expertise area and form a link for collaborations between industry-academic scientists and clinical researchers. Multifunctional Drug Delivery: Expectations and Realities, Ranjita Shegokar
(editor), Volume 4 – Drug Delivery Aspects, Elsevier Int (Q1/2020) |
volume
4 |
|
|
Metal Nanoparticles in PharmaEdited by Ranjita Shegokar
Completely dedicated to the biomedical applications of metal
nanoparticles, this book covers the different toxicity problems found in
healthcare situations and also provides comprehensive info on the use of metal
nanoparticles in treating various diseases. Metal Nanoparticles in Pharma is
the first edited volume to set up the discussion for a clinical setting and to
target a pharmaceutical audience of academic and industry-based researchers
Metal Nanoparticles in Pharma, Mahendra Rai and Ranjita Shegokar (Editors)
Springer publishing house, proposed publication, ISBN 978-3-319-63789-1
(Hard cover) / ebook |
|
|
Emerging Nanotechnologies in ImmunologyEdited by Ranjita Shegokar
Emerging Nanotechnologies in Immunology aims to deliver a systematic and comprehensive review of data concerning the nature of interaction and nano-related risks between the nanophamaceuticals currently in the pipeline of S&T development for skin, ocular, and nasal drug delivery, including absorption, toxicity, and the ability to distribute after systemic exposure. The scientific development of manufactured nanomaterials for drug delivery is increasing rapidly. One of the most prominent applications is topical drug delivery, where cutaneous, ocular, and nasal exposure becomes even more relevant. These targets are the first barrier that nanoparticles encounter when in contact with the human body. The contributors addresses a representative set of the broad spectrum of nanopharmaceuticals currently being used, including cationic lipid nanoparticles, polymeric PLGA, PLA nanoparticles, biomacromolecules-based nanoparticles, and other scaffolds tissue engineered skin substitutes. Regulation and risk is also covered, since the safety of these nanophamaceuticals still represents a barrier to their wide innovative use. View less > “Emerging Nanotechnologies in Immunology: The Design, Application and
Toxicology of Nanopharmaceuticals and Nanovaccines” Edited by Shegokar
R., and Souto E.B. Elsevier Int publishing house, |
|
vol
1
|
NanopharmaceuticalsEdited by Ranjita Shegokar
Nanopharmaceuticals reviews advances in the drug delivery field via nanovehicles or nanocarriers that offer benefits like targeted therapy and serves as a single dose magic bullet for multiple drug delivery with improved drug efficiency at a lower dose, transportation of the drug across physiological barriers as well as reduced drug-related toxicity. The chapters are written by a diverse group of international researchers from industry and academia. The series Expectations and Realities of Multifunctional Drug Delivery Systems examines the fabrication, optimization, biological aspects, regulatory and clinical success of wide range of drug delivery carriers. This series reviews multifunctionality and applications of drug delivery systems, industrial trends, regulatory challenges and in vivo success stories. Throughout the volumes discussions on diverse aspects of drug delivery carriers, such as clinical, engineering, and regulatory, facilitate insight sharing across expertise area and form a link for collaborations between industry-academic scientists and clinical researchers. Multifunctional Drug Delivery systems: Expectations and Realities, Ranjita
Shegokar (editor) Volume 1 – Nanopharmaceuticals, Elsevier Int (Q1/2020) |
|
vol
2
|
Delivery of DrugsEdited by Ranjita Shegokar
Delivery of Drugs: Expectations and Realities of Multifunctional Drug Delivery Systems, Volume Two examines the formulation of micro-nanosized drug delivery systems and recaps opportunities for using physical methods to improve efficacy via mechano-, electroporation. The book highlights innovative delivery methods like PIPAC, including discussions on the regulatory aspects of complex injectables. Written by a diverse range of international researchers from industry and academia, the chapters examine specific aspects of characterization and manufacturing for pharmaceutical applications as well as regulatory and policy aspects. This book connects formulation scientists, regulatory experts, engineers,
clinical experts and regulatory stakeholders. This level of discussion makes
it a valuable reference resource for researchers in both academia and the
pharmaceutical industry who want to learn more about the status of drug
delivery systems. Multifunctional Drug Delivery:Expectations and Realities, Ranjita Shegokar
(editor), Volume 2 – Delivery of Drugs, Elsevier Int (Q1/2020) |
|
vol
3
|
Drug Delivery TrendsEdited by Ranjita Shegokar
Drug Delivery Trends examines a drift in the pharmaceutical field across the wide range of dosage forms, drug delivery systems (micro and nanoparticulate), at the regulatory front and on new types of therapies in the market. This volume additionally covers the challenges on drug delivery systems in terms of preclinical and current ways of determining quality and the options to solve the challenges associated with this. Most small-medium scale industries and academics struggle with initial regulatory challenges so a detailed discussion on regulatory trend covers the necessary basic understanding of regulatory procedures and provides the required guidance. The series Expectations and Realities of Multifunctional Drug Delivery Systems examines the fabrication, optimization, biological aspects, regulatory and clinical success of wide range of drug delivery carriers. This series reviews multifunctionality and applications of drug delivery systems, industrial trends, regulatory challenges and in vivo success stories. Throughout the volumes discussions on diverse aspects of drug delivery carriers, such as clinical, engineering, and regulatory, facilitate insight sharing across expertise area and form a link for collaborations between industry-academic scientists and clinical researchers. Multifunctional Drug Delivery: Expectations and Realities, Ranjita Shegokar
(editor), Volume 3 – Drug Delivery Trends, Elsevier Int (Q1/2020) |
|
vol
4
|
Drug Delivery AspectsEdited by Ranjita Shegokar
Drug Delivery Aspects reviews additional features of drug delivery systems, along with the standard formulation development, like preclinical testing, conversion into solid dosage forms, roles of excipients and polymers used on stability and sterile processing. There is a focus on formulation engineering and related large scale (GMP) manufacturing, regulatory, and functional aspects of drug delivery systems. A detailed discussion on biologics and vaccines gives insights to readers on new developments in this direction. The series Expectations and Realities of Multifunctional Drug Delivery Systems examines the fabrication, optimization, biological aspects, regulatory and clinical success of wide range of drug delivery carriers. This series reviews multifunctionality and applications of drug delivery systems, industrial trends, regulatory challenges and in vivo success stories. Throughout the volumes discussions on diverse aspects of drug delivery carriers, such as clinical, engineering, and regulatory, facilitate insight sharing across expertise area and form a link for collaborations between industry-academic scientists and clinical researchers. Multifunctional Drug Delivery: Expectations and Realities, Ranjita Shegokar
(editor), Volume 4 – Drug Delivery Aspects, Elsevier Int (Q1/2020) |